Drugs / Gynodian® Depot
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00463450 | May 2002 → Apr 2004 | — | Bayer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gynodian Depot | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00463450 ↗ |
| Known as | BAY86-5032 | “Gynodian® Depot (BAY86-5032)” NCT00463450 ↗ |
| Modality | Other / unclassified | “Gynodian? Depot as a combination of estrogen and androgen” NCT00463450 ↗ |